The discovery of the pro-fibrilization solution environment may help optimize RT-QuiC/PMCA assay that has been recently used in ultra-micro detecting α-synuclein aggregates in the body fluid or skin tissue of PD patients. Here, SNCA is linked to Parkinson disease.